6MV

4-[2-fluoro-3-(4-oxoquinazolin-3(4H)-yl)phenyl]-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide

Created:	2016-05-09
Last modified:	2016-08-31

Find Related PDB Entry
1 entries where 6MV is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	61
Chiral Atom Count	0
Bond Count	66
Aromatic Bond Count	27

2D diagram of 6MV

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-[2-fluoro-3-(4-oxoquinazolin-3(4H)-yl)phenyl]-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide
Systematic Name (OpenEye OEToolkits)	4-[2-fluoranyl-3-(4-oxidanylidenequinazolin-3-yl)phenyl]-7-(2-oxidanylpropan-2-yl)-9~{H}-carbazole-1-carboxamide
Formula	C₃₀ H₂₃ F N₄ O₃
Molecular Weight	506.527
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c6c5c1c(c(ccc1c2cccc(c2F)N4C(=O)c3c(cccc3)N=C4)C(N)=O)nc5cc(C(C)(C)O)c6
SMILES	CACTVS	3.385	CC(C)(O)c1ccc2c([nH]c3c(ccc(c4cccc(N5C=Nc6ccccc6C5=O)c4F)c23)C(N)=O)c1
SMILES	OpenEye OEToolkits	2.0.4	CC(C)(c1ccc2c(c1)[nH]c3c2c(ccc3C(=O)N)c4cccc(c4F)N5C=Nc6ccccc6C5=O)O
Canonical SMILES	CACTVS	3.385	CC(C)(O)c1ccc2c([nH]c3c(ccc(c4cccc(N5C=Nc6ccccc6C5=O)c4F)c23)C(N)=O)c1
Canonical SMILES	OpenEye OEToolkits	2.0.4	CC(C)(c1ccc2c(c1)[nH]c3c2c(ccc3C(=O)N)c4cccc(c4F)N5C=Nc6ccccc6C5=O)O
InChI	InChI	1.03	InChI=1S/C30H23FN4O3/c1-30(2,38)16-10-11-19-23(14-16)34-27-21(28(32)36)13-12-17(25(19)27)18-7-5-9-24(26(18)31)35-15-33-22-8-4-3-6-20(22)29(35)37/h3-15,34,38H,1-2H3,(H2,32,36)
InChIKey	InChI	1.03	WYDRUGJOWSJDHU-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3977725
PubChem	121499156
ChEMBL	CHEMBL3977725

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.